Cart
sales@molnova.com
(S)-ErSO
CAS No. 2407860-34-6
(S)-ErSO( —— )
Catalog No. M28246 CAS No. 2407860-34-6
(S)-ErSO is an inactive dextrorotatory enantiomer of ErSO.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 186 | In Stock |
|
| 10MG | 320 | In Stock |
|
| 25MG | 507 | In Stock |
|
| 50MG | 686 | In Stock |
|
| 100MG | 912 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(S)-ErSO
-
NoteResearch use only, not for human use.
-
Brief Description(S)-ErSO is an inactive dextrorotatory enantiomer of ErSO.
-
Description(S)-ErSO is an inactive dextrorotatory enantiomer of ErSO.(In Vitro):(S)-ErSO is inactive in MCF-7 cells while (R)-ErSO induces dose-dependent death.
-
In Vitro(-)-ErSO induces dose-dependent death of MCF-7 cells. (+)-l05 is inactive.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorEPAC1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2407860-34-6
-
Formula Weight453.33
-
Molecular FormulaC22H13F6NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 190 mg/mL (419.12 mM)
-
SMILESO=C1[C@](C=2C(N1)=C(C(F)(F)F)C=CC2)(C3=CC=C(OC(F)(F)F)C=C3)C4=CC=C(O)C=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Brown LM, et al. Allosteric inhibition of Epac: computational modeling and experimental validation to identify allosteric sites and inhibitors. J Biol Chem. 2014 Oct 17;289(42):29148-57.
molnova catalog
related products
-
L-Phenylalanine beta...
L-Phenylalanine betaine
-
Murlentamab
Murlentamab (GM102) is a humanized anti-AMhRII antibody.
-
Atrial Natriuretic F...
Anaritide is a synthetic form of atrial natriuretic peptide (ANP) composed of 25 amino acids. Anaritide increases glomerular filtration rate by dilating into and contracting out the bulbar arterioles. Anaritide can be used to study the effects on patients with acute tubular necrosis, particularly in improving dialysis free survival.
